drugset / Trial / NCT01993849

Use of N-Acetylcysteine (NAC) in Fingernail Biting

NCT01993849

Phase 3 Completed 23 enrolled Kevin Gray, MD
RandomizedParallel-groupDouble-blindTreatment

Summary

To conduct a pilot randomized placebo-controlled feasibility trial of N-acetylcysteine (NAC) in onychophagia, preliminarily assessing the tolerability and effects of this pharmacotherapy on young adults who bite their fingernails. It is proposed that NAC will help decrease fingernail biting.

Timeline

Start
2013-10
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator N-acetylcysteine Small molecule 1200 mg Oral

Indications